Baystreet.ca - Processa Positive on Trumpeting Convention Appearance
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) shares gained ground Friday, as the company, a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...
David Young Research Forum Session Processa Pharmaceuticals Inc Processa Pharmaceuticals Digestive Disease Week Mccormick Place
Source: baystreet.ca